Ramachandaram, A. (2023) “REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE”, Journal of the ASEAN Federation of Endocrine Societies, 38(S3), p. 52. doi: 10.15605/jafes.038.AFES.74.